Loading...
  • angina pectoris
  • 11. Method for treatment and/or prevention of heart failure, angina pectoris, hypertension, pulmonary hypertension, thromboembolic disorders, ischaemias, vascular disorders, impaired microcirculation, renal insufficiency, fibrotic disorders and arteriosclerosis in humans and animals by administration of an effective amount of at least one compound as defined in claim 1 to a human or animal in need thereof. (patentsencyclopedia.com)
  • 12. A method for the treatment and/or prevention of heart failure, angina pectoris, hypertension, pulmonary hypertension, thromboembolic disorders, ischaemias, vascular disorders, impaired microcirculation, renal insufficiency, fibrotic disorders and arteriosclerosis in humans and animals by administration of an effective amount of the medicament of claim 8 to a human or animal in need thereof. (patentsencyclopedia.com)
  • 10. Method for the treatment and/or prevention of heart failure, angina pectoris, hypertension, pulmonary hypertension, thromboembolic disorders, ischaemias, vascular disorders, microcirculation impairments, renal insufficiency, fibrotic disorders and arteriosclerosis comprising administering an effective amount of at least one compound of claim 1 to a human or animal in need thereof. (patentsencyclopedia.com)
  • 11. A method for the treatment and/or prevention of heart failure, angina pectoris, hypertension, pulmonary hypertension, thromboembolic disorders, ischaemias, vascular disorders, microcirculation impairments, renal insufficiency, fibrotic disorders and arteriosclerosis comprising administering an effective amount of a pharmaceutical composition of claim 7 to a human or animal in need thereof. (patentsencyclopedia.com)
  • Resuscitation
  • These achievements mainly included the Chinese Rule of Nine, fluid resuscitation protocol, experience in inhalation injury, wound treatment strategies, prevention and treatment of burn infections, nutrition therapy, organ support therapies, and rehabilitation. (biomedcentral.com)
  • tissue
  • Genomics and critical care, tissue factor and activated protein C, genetic analysis, latent mediators, and other problems, and the possibility of multiple or combination therapy are on the horizon. (springer.com)
  • severity
  • No differences were found referring to age, gender, injury distribution or overall injury severity between children with and without MODS. (biomedcentral.com)
  • However, increased IL-6 levels during the first two days were no longer associated with the injury severity but a significant correlation to MODS was measured. (biomedcentral.com)
  • The presented prospective study is the first providing evidence for a correlation of IL-6 levels with injury severity and the incidence of MODS in traumatized children. (biomedcentral.com)
  • therapy
  • Our aim was to review the relevant findings of research articles that were published in 2010 in Critical Care and that focused on advances in the understanding of MODS physiopathology, diagnostic and prognostic marker evaluation, and novel therapy strategies. (biomedcentral.com)
  • involve
  • For instance, the methods involve contacting organ(s) with an oxygenated cholesterol sulfate (OCS), e.g. 5-cholesten-3,25-diol, 3-sulfate (25HC3S). (justia.com)